Revance Therapeutics Inc (NASDAQ:RVNC)

Delayed Data
As of Aug 16
 +0.18 / +0.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Revance Therapeutics Inc have a median target of 26.00, with a high estimate of 55.00 and a low estimate of 22.00. The median estimate represents a +16.59% increase from the last price of 22.30.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Revance Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.86%
Growthannually 14.02%


Growthquarterly -0.75%
Growthannually 53.56%
Key to the earnings and sales forecast charts.